Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Valeria Nucera
Observed names:
NUCERA, Valeria,
Nucera Valeria,
Nucera, Valeria,
Nucera, Veleria,
V. Nucera,
Valeria NUCERA
show all 6
Institution:
University of Messina
Observed institutions:
University of Messina,
Santissima Trinità,
ASST Fatebenefratelli Sacco,
Hermanas Hospitalarias del Sagrado Corazón de Jesús
ORCID:
0000-0002-6642-3626
Observed ORCID:
0000-0002-6642-3626
OpenAlex ID:
A5050331036
One year in review 2021: fibromyalgia
2021
·
Alessandra Alciati
, Valeria Nucera
, et al.
·
Clinical and Experimental Rheumatology
·
211
PDF
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
2020
·
Giulia Cassone
, Andreina Manfredi
, et al.
·
Journal of Clinical Medicine
·
78
PDF
Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab
2019
·
Fabiola Atzeni
, Valeria Nucera
, et al.
·
Pharmacological Research
·
71
Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review
2019
·
Fabiola Atzeni
, Valeria Nucera
, et al.
·
Expert Opinion on Biological Therapy
·
64
From autoinflammation to autoimmunity: old and recent findings
2018
·
Francesco Caso
, Luisa Costa
, et al.
·
Clinical Rheumatology
·
54
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis
2022
·
Gian Luca Erre
, Fabio Cacciapaglia
, et al.
·
European Journal of Internal Medicine
·
52
Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events
2022
·
Fabiola Atzeni
, Călin D. Popa
, et al.
·
Expert Review of Clinical Immunology
·
45
Behçet disease: From pathogenesis to novel therapeutic options
2021
·
Javier Rodríguez-Carrio
, Valeria Nucera
, et al.
·
Pharmacological Research
·
44
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors
2018
·
Fabiola Atzeni
, Rossella Talotta
, et al.
·
Expert Review of Clinical Immunology
·
32
The Rheumatology Drugs for COVID-19 Management: Which and When?
2021
·
Fabiola Atzeni
, Ignazio Francesco Masala
, et al.
·
Journal of Clinical Medicine
·
29
PDF
Cardiovascular Consequences of Autoimmune Rheumatic Diseases
2020
·
Fabiola Atzeni
, Valeria Nucera
, et al.
·
Current Vascular Pharmacology
·
21
Concerns about the safety of anti-TNF agents when treating rheumatic diseases
2020
·
Fabiola Atzeni
, Valeria Nucera
, et al.
·
Expert Opinion on Drug Safety
·
20
One year in review 2021: fibromyalgia
2021
·
Alciati, Alessandra
, Nucera, Veleria
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
·
19
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study
2023
·
Marino Paroli
, Andrea Becciolini
, et al.
·
Medicina
·
18
PDF
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy
2024
·
Marino Paroli
, Andrea Becciolini
, et al.
·
Journal of Clinical Medicine
·
14
PDF
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients
2024
·
Simone Parisi
, Becciolini Andrea
, et al.
·
Current Research in Pharmacology and Drug Discovery
·
11
PDF
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup—A Multicenter Study
2024
·
Marta Priora
, Andrea Becciolini
, et al.
·
Medicina
·
10
PDF
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study
2023
·
Alberto Lo Gullo
, Andrea Becciolini
, et al.
·
Journal of Clinical Medicine
·
7
PDF
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study
2023
·
Andrea Becciolini
, Simone Parisi
, et al.
·
Biomedicines
·
7
PDF
Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis
2019
·
Francesca Marino
, Valeria Nucera
, et al.
·
Pharmacological Research
·
7
The effect of drugs used in rheumatology for treating SARS-CoV2 infection
2020
·
Fabiola Atzeni
, Elisabetta Gerratana
, et al.
·
Expert Opinion on Biological Therapy
·
5
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study
2025
·
Andrea Becciolini
, Antonio Marchesoni
, et al.
·
Rheumatology Advances in Practice
·
4
PDF
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study
2025
·
Camilla Mazzanti
, Marino Paroli
, et al.
·
Journal of Psoriasis and Psoriatic Arthritis
·
4
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis
2024
·
Alberto LO GULLO
, Simone PARISI
, et al.
·
Minerva Medica
·
4
Toxicological considerations in the treatment of axial spondylo-arthritis
2020
·
Francesca Marino
, Salvatore D’Angelo
, et al.
·
Expert Opinion on Drug Metabolism & Toxicology
·
4
Show more works
View as search
Works count:
67
Citation count:
852
H-index:
14
I10-index:
17
Year
Topic
Type